Net profit of Cohance Lifesciences declined 35.15% to Rs 48.88 crore in the quarter ended June 2025 as against Rs 75.37 crore during the previous quarter ended June 2024. Sales rose 12.55% to Rs 549.31 crore in the quarter ended June 2025 as against Rs 488.08 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 549.31 | 488.08 | 13 |
| OPM % | 20.39 | 25.63 | - |
| PBDT | 116.00 | 134.31 | -14 |
| PBT | 70.86 | 103.03 | -31 |
| NP | 48.88 | 75.37 | -35 |